Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02412241 · ClinicalTrials.gov registry record · NA
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT02412241 is a NA study that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 118 participants.
The verdict
NCT02412241, a NA study, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
This four-year, prospective, longitudinal study will evaluate and validate a patient-reported outcome measure, clinician-reported outcome measures, and imaging techniques in assessing characteristics, trajectory, and progression of lymphedema and fibrosis (LEF) in oral cavity and oropharyngeal cancer patients. This clinical trial studies patient-and-clinician-reported measures as well as standard imaging methods to see how accurate they are in identifying and evaluating lymphedema (swelling) or fibrosis (tough or tight tissue) in the head and neck region of patients receiving treatment for newly diagnosed stage II-IV oral cavity or oropharyngeal cancer. Lymphedema and fibrosis (LEF) can lead to physical symptoms, such as trouble swallowing and chewing, as well as psychological and emotional symptoms, such as negative body image and avoiding social interactions. Finding an accurate test to identify and evaluate LEF may allow doctors to treat LEF more quickly and control symptoms more effectively, and thus provide patients with a better quality of life.
Interventions
- OTHER LEF measures
- PROCEDURE Technical measure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02412241
The ClinicalTrials.gov registry entry for NCT02412241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LEF measures is the first listed.
NCT02412241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02412241 about?
NCT02412241 is a clinical study titled "Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients". This four-year, prospective, longitudinal study will evaluate and validate a patient-reported outcome measure, clinician-reported outcome measures, and imaging techniques in assessing characteristics, trajectory, and progression of lymphedema and fibrosis (LEF) in oral cavity and oropharyngeal cance...
What is the current status of trial NCT02412241?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2015-06. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02412241?
The interventions under investigation include: LEF measures (OTHER), Technical measure (PROCEDURE).
Who is sponsoring clinical trial NCT02412241?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.